logo
  

Citrix Systems Q3 Profit Decreases - Quick Facts

Citrix Systems, Inc. (CTXS) reported third-quarter net income of $48 million, or $0.29 per share, compared to $77 million, or $0.41 per share, for the third quarter of fiscal year 2013. GAAP results for the third quarter of fiscal year 2014 include a charge of approximately $21 million related to a previously disclosed patent lawsuit, as well as a restructuring charge of $3 million for severance costs incurred to better align resources to strategic initiatives. Non-GAAP net income for the third quarter of fiscal year 2014 was $125 million, or $0.75 per share.

On average, 31 analysts polled by Thomson Reuters expected the company to report profit per share of $0.73 for the quarter. Analysts' estimates typically exclude special items.

Revenue was $759 million, compared to $713 million in the third quarter of fiscal year 2013, representing 6 percent revenue growth. Analysts expected revenue of $771.79 million for the quarter.

"While our results were clearly mixed, we executed well in many important areas including product releases, go-to market investments and partnership initiatives, all while maintaining focus on operational refinements and profitability," said Mark Templeton, CEO for Citrix.

For the fiscal year ending December 31, 2014, Citrix expects: net revenue to be in the range of $3.13 billion to $3.14 billion; GAAP earnings per share to be in the range of $1.57 to $1.58; and Non-GAAP earnings per share to be in the range of $3.22 to $3.25. Analysts expect the company to report fiscal 2014 earnings per share of $3.24 on revenue of $3.18 billion.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Philip Morris International Inc. (PM) reported Tuesday that net earnings attributable to PMI for the quarter grew to $2.15 billion or $1.38 per share from $2.00 billion or $1.28 per share in the prior-year quarter. Excluded items, adjusted earnings for the quarter were $1.50 per share, compared to... Novartis AG's shares were gaining more than 4 percent in Switzerland and more than 5 percent in pre-market activity on the NYSE after the Swiss drug major reported Tuesday higher first-quarter profit, above market estimates, with strong sales growth. The company also raised its fiscal 2024 outlook for growth in sales and core operating income. Primal Kitchen is recalling around 2,060 cases of three code dates of Primal Kitchen Avocado Oil as the glass may be prone to breakage, causing the product to spill, the U.S. Food and Drug Administration noted. The recall involves 750mL Primal Kitchen Avocado Oil with an individual package UPC of 8-5523200719-4.

First quarter growth data from China gained the maximum focus this week as trends in the massive emerging economy impact its trading partners. Elsewhere, the IMF released its latest global macroeconomic projections. Read our story to find out why comments from the Fed Chair Powell damped rate cut expectations. Meanwhile, there was some survey data that kindled hopes of a recovery in manufacturing. In the U.K., inflation data for March revealed some confusing trends.

View More Videos
Follow RTT